Pilotstudy to characterise prostate tissue using dynamic contrast enhanced (DCE-) MRI in patients with localised prostate cancer.

Pilotstudy to characterise prostate tissue using dynamic contrast enhanced (DCE-) MRI in patients with localised prostate cancer. - The relation between DCE-MRI and prostatectomy specimen

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31676

Enrollment

Registered

2008-01-10

Start date

2008-11-28

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blood perfusion prostate cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who will receive a prostatectomy as treatment for a locallised prostate cancer

Exclusion criteria

Exclusion criteria: No contraindications for a 3.0 T MRI

Design outcomes

Primary

Measure	Time frame
The interpretation of the DCE-MRI will be in terms of vasculature, microvessel density and the amount of vessel leakage. The first question is whether this interpretation has it's basis in histology.	—

Secondary

Measure	Time frame
The second question is whtether these histologic characterisations can be correlated with the presence of tumour and it's oxygenation.	—

Countries

Netherlands

Outcome results